Subscribe
Home Economics GSK says sells thrombosis brands, French plant

GSK says sells thrombosis brands, French plant

When you purchase through our sponsored links, we may earn a commission. By using this website you agree to our T&Cs.

GSK says sells thrombosis brands, French plant (via AFP)

British drugs firm GlaxoSmithKline (GSK) said Monday that it has sold two thrombosis brands and a French plant to South African peer Aspen for £700 million ($1.13 billion, 834 million euros). “GSK today announced it has reached agreement to sell its…

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

AFP
Editor

Related news

S&P 500 Hits All-Time High as Q2 Earnings Season Kicks Off
Dave Kovaleski
Inflation rate
Inflation Falls to 3% in June – A Kickstarter for Rate Cuts?
Dave Kovaleski
Jerome Powell discussed interest rate decisions
Fed Chair Jerome Powell: “Two-Sided Risks” to Interest Rate Decisions
Dave Kovaleski
FOMC Member
There are ‘Several Reasons’ to Be Optimistic About Inflation, According to FOMC Member
Dave Kovaleski
Inflation Rates
How Low Will Inflation Rates Be One Year From Now?
Dave Kovaleski

Must Read

New

How to Invest in Stocks in 2024 – Beginner’s Guide

Investing in stocks can be a great way to improve your overall wealth – but...

23 Min Read Read now

Latest News

Bank stocks
Banking

Synchrony, Ally, and U.S. Bancorp Beat Estimates: Which Bank Stock is the Better Buy?
Dave Kovaleski17 hours

Three big banks posted earnings Wednesday: Here’s how they did. Bank stocks traditionally kick off every earnings season, and they often prove to be bellwethers for earnings for that particular...

Categories

Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.